A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints

被引:10
|
作者
Natarajan, R
Turnbull, BW
Slate, EH
Clark, LC
机构
[1] CORNELL UNIV,SCH OPERAT RES & IND ENGN,ITHACA,NY 14853
[2] UNIV ARIZONA,CTR CANC,TUCSON,AZ
基金
美国国家卫生研究院;
关键词
clinical trials; power; sample size; multiple treatments; factorial design; treatment lag; multiple comparisons; Fisher's LSD; stratification; Monte Carlo method;
D O I
10.1016/0169-2607(96)01717-8
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
This paper presents a computer program for use in the design of long-term clinical trials with multiple treatment arms in which the primary outcome variables are censored survival times, The treatment arms may be structured as a one-way or multi-way factorial design. It is assumed that patients are entered and randomized to a treatment arm during an accrual period. The patients are then followed for a fixed period during which there may be dropouts. Various distributional assumptions can be used to model the survival times. These include an option in which there is an effect of treatment duly after a lag or delay time. The program then computes the power of various statistical tests of hypotheses concerning treatment differences, interactions and trends. The power computations are ''exact'' in that they use the Monte Carlo method to obtain Type I and II error probabilities. However the program also outputs the normal approximations for comparison, although they are typically not accurate in these situations. Fisher's LSD method is used to adjust for the multiple comparisons. By comparing the power for various sets of design parameters, such as sample size, numbers of factor levels, patient accrual rate, and length of follow-up, an appropriate design can be constructed. Two examples are provided. The first is a simple one-way layout with multiple treatment arms; the second a two-way factorial design for a proposed large scale cancer chemoprevention trial.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 50 条
  • [21] Current Practice on Multiplicity Adjustment and Sample Size Calculation in Multi-arm Clinical Trials: An Industry Survey in Japan
    Sakamaki, Kentaro
    Kamiura, Toshifumi
    Morita, Yusuke
    Iba, Katsuhiro
    Yoshida, Seitaro
    Wakana, Akira
    Tsuchiya, Satoru
    Fukimbara, Satoru
    Suganami, Hideki
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (06) : 846 - 852
  • [22] Multi-arm multi-stage clinical trials for time-to-event outcomes
    Dixit, Vaidehi
    Mitra, Priyam
    Simonsen, Katy
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2021, 31 (06) : 838 - 851
  • [23] A multi-stage drop-the-losers design for multi-arm clinical trials
    Wason, James
    Stallard, Nigel
    Bowden, Jack
    Jennison, Christopher
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2017, 26 (01) : 508 - 524
  • [24] Considerations on sample size and power calculations in randomized clinical trials
    Karlsson, J
    Engebretsen, L
    Dainty, K
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2003, 19 (09): : 997 - 999
  • [25] Optimal adaptive generalized Polya urn design for multi-arm clinical trials
    Yuana, Ao
    Chai, Gen Xiang
    JOURNAL OF MULTIVARIATE ANALYSIS, 2008, 99 (01) : 1 - 24
  • [26] POWER AND SAMPLE-SIZE CALCULATIONS - A REVIEW AND COMPUTER-PROGRAM
    DUPONT, WD
    PLUMMER, WD
    CONTROLLED CLINICAL TRIALS, 1990, 11 (02): : 116 - 128
  • [27] Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer
    Royston, P
    Parmar, MKB
    Qian, W
    STATISTICS IN MEDICINE, 2003, 22 (14) : 2239 - 2256
  • [28] Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple Endpoints
    Mulier, Guillaume
    Chevret, Sylvie
    Lin, Ruitao
    Biard, Lucie
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024, 16 (03): : 315 - 325
  • [29] Biomarker-guided clinical trial designs: sample size calculations with survival endpoints
    Antoniou, Miranta
    Kolamunnage-Dona, Ruwanthi
    Jorgensen, Andrea L.
    TRIALS, 2017, 18
  • [30] Sample Size Issues for Cluster Randomized Trials With Discrete-Time Survival Endpoints
    Moerbeek, Mirjam
    METHODOLOGY-EUROPEAN JOURNAL OF RESEARCH METHODS FOR THE BEHAVIORAL AND SOCIAL SCIENCES, 2012, 8 (04) : 146 - 158